Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
LONDON - SWS Holdings Limited announced Tuesday that its proposed scheme of arrangement has been approved by the required majority of creditors, marking a key step in the company’s financial restructuring efforts.
The scheme, proposed under Part 26 of the Companies Act 2006, received support from more than 75 percent in value of creditors who participated in the scheme meetings, either in person or by proxy. The approval comes ahead of a court sanction hearing scheduled for October 9, 2025, where the High Court of Justice of England and Wales will consider final approval.
According to the company’s statement, the scheme represents "the only implementable solution to enable the equity investment required to provide stability and certainty in the longer term."
The chairperson’s report regarding the scheme meetings and the notice of approval have been made available on the scheme website. Affected creditors with questions about accessing these documents have been directed to contact the information agent.
The announcement was made via a regulatory news service filing by SW (Finance) I PLC, which released the statement based on information from SWS Holdings Limited, the scheme company.
If sanctioned by the court next month, the scheme will become legally binding on all scheme creditors, regardless of whether they voted in favor of the arrangement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.